全文获取类型
收费全文 | 211076篇 |
免费 | 3030篇 |
国内免费 | 197篇 |
专业分类
耳鼻咽喉 | 1542篇 |
儿科学 | 7101篇 |
妇产科学 | 3389篇 |
基础医学 | 21177篇 |
口腔科学 | 2596篇 |
临床医学 | 14779篇 |
内科学 | 39552篇 |
皮肤病学 | 1579篇 |
神经病学 | 18971篇 |
特种医学 | 10251篇 |
外科学 | 35016篇 |
综合类 | 2482篇 |
一般理论 | 2篇 |
预防医学 | 19196篇 |
眼科学 | 3453篇 |
药学 | 12069篇 |
中国医学 | 674篇 |
肿瘤学 | 20474篇 |
出版年
2023年 | 194篇 |
2022年 | 363篇 |
2021年 | 792篇 |
2020年 | 447篇 |
2019年 | 568篇 |
2018年 | 22488篇 |
2017年 | 17837篇 |
2016年 | 20021篇 |
2015年 | 1583篇 |
2014年 | 1707篇 |
2013年 | 1857篇 |
2012年 | 8581篇 |
2011年 | 22743篇 |
2010年 | 19793篇 |
2009年 | 12357篇 |
2008年 | 20953篇 |
2007年 | 23201篇 |
2006年 | 2204篇 |
2005年 | 3977篇 |
2004年 | 5024篇 |
2003年 | 5977篇 |
2002年 | 4028篇 |
2001年 | 1582篇 |
2000年 | 1770篇 |
1999年 | 1398篇 |
1998年 | 651篇 |
1997年 | 576篇 |
1996年 | 447篇 |
1995年 | 417篇 |
1994年 | 372篇 |
1993年 | 317篇 |
1992年 | 877篇 |
1991年 | 827篇 |
1990年 | 862篇 |
1989年 | 788篇 |
1988年 | 777篇 |
1987年 | 673篇 |
1986年 | 647篇 |
1985年 | 633篇 |
1984年 | 415篇 |
1983年 | 348篇 |
1982年 | 182篇 |
1980年 | 181篇 |
1979年 | 324篇 |
1978年 | 213篇 |
1977年 | 155篇 |
1975年 | 156篇 |
1974年 | 236篇 |
1973年 | 154篇 |
1972年 | 165篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
41.
T. Akatsu T. Murakami K. Ono M. Nishikawa E. Tsuda S.-I. Mochizuki N. Fujise K. Higashio K. Motoyoshi M. Yamamoto N. Nagata 《BONE》1998,23(6):495-498
Osteoclastogenesis inhibitory factor (OCIF) is a novel secreted protein that inhibits osteoclastogenesis both in vitro and in vivo. In this study, we examined the effects of OCIF on serum calcium (Ca) concentrations in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. In normal mice, a single intraperitoneal injection of OCIF reduced serum Ca levels in a dose-dependent manner. Significant decrease in serum Ca (by 1.6 ± 0.3 mg/dL, n = 5) was observed 2 h after the injection of OCIF at 20 mg/kg and the hypocalcemic effect continued for up to 12 h. Serum phosphate (Pi) concentrations also decreased in response to OCIF. Urinary excretion of Ca, Pi, and creatinine did not change significantly after injection of OCIF or vehicle. In hypercalcemic, tumor-bearing nude mice, a single intraperitoneal injection of OCIF at 20 mg/kg resulted in a dramatic decrease in serum Ca (maximal decrease 2.8 ± 0.37 mg/dL, n = 11), which continued for up to 24 h. The results suggest that OCIF decreased serum Ca through its inhibitory effect on bone resorption. Furthermore, it is suggested that OCIF has therapeutic potential for the treatment of hypercalcemic conditions such as malignancy-associated hypercalcemia. 相似文献
42.
Xin Mei Jiang Akio Ohnishi Tatsunori Yamamoto Yoshiyuki Murai Akira Awaya Masato Ikeda 《Acta neuropathologica》1995,90(2):130-134
One of the pyrimidine compounds, 2-piperadino-6-methyl-5-oxo-5,6-dihydro(7H)pyrrolo[3,4-d]pyrimidine (MS-818), has neurotropic effects in vitro. Therefore, we studied the effect of MS-818 on the regeneration of the peroneal nerve in C57BL/6J mice after a crush injury. Two test groups, which received a daily intraperitoneal injection of 5 mg/kg or 10 mg/kg MS-818, respectively, were compared with controls, which received daily intraperitoneal injections of physiological saline, over a 14-day period. The maximum foot-width ratio (crushed side/uncrushed side) was obtained on days 1, 8 and 14 after the crush injury, and the various morphometric parameters were evaluated at both 5 and 10 mm distal to the proximal portion of the crush site. The significant effects of MS-818 included a larger maximum foot width (P<0.04) and a greater number of unmyelinated axons per nerve at both levels (P<0.003) in both test groups than in controls. MS-818 had no significant effects on body weight, the increase of total transverse fascicular area after the crush injury, the total number of myelinated fibers with their size distributions, or the number of nuclei of Schwann cells and macrophages. Therefore, we conclude that MS-818 promotes axonal sprouting and elongation after a crush injury in mice. 相似文献
43.
H Murakami M Togawa S Takahashi N Kasahara J Yamamoto N Matsuura Y Koshiyama Y Ino M Oda 《Arzneimittel-Forschung》1990,40(12):1352-1358
The effects of FUT-187 (6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate, CAS 103926-82-5), a novel synthetic protease inhibitor, were examined in experimental rat and canine models of pancreatitis. 1. FUT-187 significantly increased the survival of rats with trypsin- and phospholipase A2-induced pancreatitis in a dose-dependent manner (10-100 mg/kg, p.o.). 2. FUT-187 decreased plasma enzymatic activity reflecting the degree of pancreatitis in rats with ethionine-induced pancreatitis, and showed a tendency to ameliorate histopathological changes in the pancreas (10-100 mg/kg p.o.). 3. FUT-187 (10 mg/kg) produced an obvious improvement of various biochemical parameters of pancreatitis and also reduced histopathological changes in the pancreas in animals with experimental pancreatitis produced by the closed duodenal loop method. In addition, FUT-187 significantly increased the survival of dogs when given by direct administration into the lumen of the closed duodenal loop. The therapeutic effects of FUT-187 in experimental pancreatitis were nearly equal in most instances to those of camostat mesilate. Thus, FUT-187 would appear to be an effective new agent for the treatment of pancreatitis. 相似文献
44.
45.
Irwin L. Flink 《Brain structure & function》2002,205(3):235-244
46.
Kentaro Yamasaki Takafumi Ishida Tatsuya Kishino Norio Niikawa 《American journal of medical genetics. Part A》2002,111(3):301-306
We report on a Thai family with dominantly inherited malformation syndrome with upper limb anomalies, short stature, quadricuspid aortic valve, and minor craniofacial anomalies. The affected individuals comprised a mildly affected mother, a moderately affected daughter, and a most severely affected son. The daughter and son had short stature. The craniofacial abnormalities comprised frontal bossing, hypoplastic nasal bones, depressed nasal bridge, and broad nasal alae. The upper limb defects varies among the patients, ranging from radial ray defects in the mother through radial and ulnar ray defects with unilateral humeral hypoplasia in the daughter to radial ray defects with severe oligodactyly and bilateral humeral hypoplasia in the son. All patients in this family had hypoplasia of the shoulder girdle and resembled what is observed in many families with Holt‐Oram syndrome. Moreover, the son showed quadricuspid aortic valve with mild aortic regurgitation. However, the present family did not show any mutation of the TBX5 gene, a disease‐causing gene of Holt‐Oram syndrome. The present family deserves further investigation on other genes that play a role in the development of the upper limbs, particularly of radial rays. © 2002 Wiley‐Liss, Inc. 相似文献
47.
48.
49.
50.